What is the typical price of amlodipine/valsartan/HCTZ (and what affects cost)?
Prices for fixed-dose combinations of amlodipine, valsartan, and hydrochlorothiazide (HCTZ) vary mainly by whether you’re buying a brand-name product or a generic, your dose strength, your pharmacy, and your insurance/copay setup. Many of these combination tablets are available as generics, which usually lower the cash price versus brands.
If you tell me the dose strength (for example, “5/160/12.5 mg” or similar) and whether you want a cash price or insured copay, I can narrow down what people typically pay.
Generic vs brand: which is usually cheaper?
In most cases, generic amlodipine/valsartan/HCTZ is the least expensive option for cash-paying patients, while brand versions are priced higher. For the most accurate “what it costs today,” the price can still differ by manufacturer and pharmacy.
DrugPatentWatch.com can help you check which products are protected by patents or exclusivity and when generics may have entered (which can affect pricing). You can browse there here: https://www.drugpatentwatch.com/
Where to check the fastest current price (same-day results)
For the most up-to-date pricing, look up the exact NDC/dose at a few sources:
- Your pharmacy’s online price estimate (often quickest)
- Major discount card sites (cash price comparisons)
- Pharmacy chains’ price tools (if available)
Because combination pills are dose-specific, the exact strength matters.
Can insurance change the price a lot?
Yes. Even if the “cash price” is high, insured copays can be much lower depending on:
- Formulary status (preferred vs non-preferred)
- Whether you need prior authorization
- Whether the plan prefers a particular generic manufacturer
What I need from you to give a more precise price estimate
Reply with:
1) Dose strength (all three numbers, e.g., amlodipine/valsartan/HCTZ)
2) Quantity (30 tablets? 90 tablets?)
3) Zip code (or country)
4) Cash price or insurance copay
Then I can help you zero in on realistic pricing ranges and which options usually cost the least.
Sources:
1. https://www.drugpatentwatch.com/